Project Grant NRCHQ11G040089

This federal Project Grant award from the Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the Grants for Education, Prevention, and Early Detection of Radiogenic Cancers and Diseases program (CFDA 93.257) provides $646,818 to IHC Health Services Inc., doing business as Intermountain Healthcare, to continue its Radiation Exposure Screening and Education Program (RESEP) Clinic. The RESEP Clinic provides cancer screening, patient education, and...

The National Cancer Institute (NCI) awarded a $898,497 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Radiopharmaceutical Imaging And Dosimetry, LLC to develop a cloud-based, customer-responsive dosimetry tool for alpha-particle emitting radiopharmaceutical therapies (ARPT). The key products and services to be delivered under this Phase II Small Business Innovation Research (SBIR) grant include: Establishing a library of microscale S-values and apportionment factors...

This U01 Cooperative Agreement award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research program) supports the development of a novel 3D in vivo dosimetry system to enable precise delivery of proton flash radiotherapy for cancer treatment. The $641,155 project, with a period of performance from August 2024 to July 2029, aims to create a robust protoacoustic/ultrasound dual-modality imaging system (PUDIS) that can verify the actual 3D dose delivered during ultra-high dose...

This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) to SRI International provides $401,125 in funding to quantify the association between genetic factors and radiation sensitivity in cancer patients. The research aims to identify germline genetic variants and gene expression patterns that contribute to individual differences in radiation response. The goal is to develop a predictive screening platform to optimize radiation dosing and mitigate...

CRDF Global will organize and conduct a two-day workshop on workforce development, regulatory development, and licensing of small modular reactors (SMRs) for at least 25 participants. Under a $168,099 cooperative agreement from the U.S. Department of State Bureau of International Security and Nonproliferation, CRDF Global will deliver this workshop in Bulgaristan between May 30, 2022 and December 31, 2023. The funding supports the State Department's Global Threat Reduction program, which aims...

CRDF Global will organize and implement a study tour for representatives from relevant nuclear energy agencies and ministries in Vietnam under a $750,000 cooperative agreement award from the U.S. Department of State Bureau of International Security and Nonproliferation. The award is part of the Department's Global Threat Reduction program (CFDA 19.033), which supports efforts to reduce threats from terrorist organizations or states of concern through cooperative programs aimed at securing...

�����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), provides $662,516 to The General Hospital Corporation (Massachusetts General Hospital) to evaluate how fractionated radiation affects drug delivery within the tumor microenvironment, and to test whether long-circulating chemotherapy can combine with standard chemoradiotherapy to safely improve treatment responses. The 5-year project will utilize in vivo imaging,...

This $400,000 project grant, awarded by the U.S. Department of Energy's National Nuclear Security Administration under the Defense Nuclear Nonproliferation Research program (CFDA 81.113), aims to improve patient care in low and middle-resource countries by increasing radiological training, knowledge, and technical assistance. Key objectives include: Engaging a global audience of radiology experts to expand radiological training, knowledge, and provide equipment/technical...

This National Cancer Institute (NCI) Project Grant award under the Cancer Cause and Prevention Research (CFDA 93.393) program seeks to develop and test a novel, comprehensive Quality Assurance (QA) device called the Retriever(TM) to improve the allocation of scarce medical physics resources. The total funding amount is $1,063,155 over a 2-year period from September 2024 to August 2026. The project aims to address the shortage of qualified medical physicists and the need for more precise and...